A frameshift in Yersinia pestis rcsD alters canonical Rcs signalling to preserve flea-mammal plague transmission cycles

  1. Xiao-Peng Guo
  2. Hai-Qin Yan
  3. Wenhui Yang
  4. Zhe Yin
  5. Viveka Vadyvaloo  Is a corresponding author
  6. Dongsheng Zhou  Is a corresponding author
  7. Yi-Cheng Sun  Is a corresponding author
  1. Chinese Academy of Medical Sciences and Peking Union Medical College, China
  2. Bengbu Medical College, China
  3. Beijing Institute of Microbiology and Epidemiology, China
  4. Washington State University, United States

Abstract

Multiple genetic changes in the enteric pathogen Yersinia pseudotuberculosis have driven the emergence of Yesinia pestis, the arthropod-borne, etiological agent of plague. These include developing the capacity for biofilm-dependent blockage of the flea foregut to enable transmission by flea bite. Previously, we showed that pseudogenisation of rcsA, encoding a component of the Rcs signalling pathway, is an important evolutionary step facilitating Y. pestis flea-borne transmission. Additionally, rcsD, another important gene in the Rcs system, harbours a frameshift mutation. Here, we demonstrated that this rcsD mutation resulted in production of a small protein composing the C-terminal RcsD histidine-phosphotransferase domain (designated RcsD-Hpt) and full-length RcsD. Genetic analysis revealed that the rcsD frameshift mutation followed the emergence of rcsA pseudogenisation. It further altered the canonical Rcs phosphorylation signal cascade, fine-tuning biofilm production to be conducive with retention of the pgm locus in modern lineages of Y. pestis. Taken together, our findings suggest that a frameshift mutation in rcsD, is an important evolutionary step that fine-tuned biofilm production to ensure perpetuation of flea-mammal plague transmission cycles.

Data availability

All data is available within the paper, its Supporting Information files, and the NCBI GenBank. RNA-seq sequencing data can be accessed in NCBI GenBank using BioProject ID: PRJNA876755.Source data files have been provided for Figures 2D, 4B, 4D, Figures 2- figure supplement 1F and 1G.

The following data sets were generated

Article and author information

Author details

  1. Xiao-Peng Guo

    Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5745-2866
  2. Hai-Qin Yan

    Department of Basic Medical Sciences, Bengbu Medical College, Bengbu, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Wenhui Yang

    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Zhe Yin

    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Viveka Vadyvaloo

    Paul G Allen School for Global Health, Washington State University, Pullman, United States
    For correspondence
    vvadyvaloo@wsu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4842-0525
  6. Dongsheng Zhou

    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
    For correspondence
    zhouds@bmi.ac.cn
    Competing interests
    The authors declare that no competing interests exist.
  7. Yi-Cheng Sun

    Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    For correspondence
    sunyc@ipbcams.ac.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5790-7071

Funding

National Major Science and Technology Projects of China (2022YFC2303202)

  • Xiao-Peng Guo

National Natural Science Foundation of China (31700072)

  • Xiao-Peng Guo

National Natural Science Foundation of China (31670139)

  • Yi-Cheng Sun

National Natural Science Foundation of China (31800120)

  • Hai-Qin Yan

the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (Project 2019HY310001)

  • Yi-Cheng Sun

the CAMS Innovation Fund for Medical Sciences (Project 2021-I2M-1-043)

  • Yi-Cheng Sun

fundamental Research Funds for the Central University (3332021092)

  • Yi-Cheng Sun

NIH Research Project Grant (R01AI117016-01A1)

  • Viveka Vadyvaloo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The animal study of flea blockage, related to Figure 5A, 5B and 5C, was performed in strict accordance with the U.S. National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (National Research Council Committee for the Update of the Guide for the and Use of Laboratory, 2011) and as approved by the Washington State University Institutional Animal Care and Use Committee, under the Animal Subject Approval Form (ASAF) 6641 and 6396.The animal study of murine infection, related to Figure 6A, 6B and 6C, was performed in strict accordance to the Guidelines for the Welfare and Ethics of Laboratory Animals of China and all the animal experiments were approved by the Institutional Animal Care Committee (IACUC) of Academy of Military Medical Sciences (AMMS), ethical approval number IACUC-DWZX-2021-057.

Copyright

© 2023, Guo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 644
    views
  • 141
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xiao-Peng Guo
  2. Hai-Qin Yan
  3. Wenhui Yang
  4. Zhe Yin
  5. Viveka Vadyvaloo
  6. Dongsheng Zhou
  7. Yi-Cheng Sun
(2023)
A frameshift in Yersinia pestis rcsD alters canonical Rcs signalling to preserve flea-mammal plague transmission cycles
eLife 12:e83946.
https://doi.org/10.7554/eLife.83946

Share this article

https://doi.org/10.7554/eLife.83946

Further reading

    1. Microbiology and Infectious Disease
    Srinivasan Vijay, Nguyen Le Hoai Bao ... Nguyen Thuy Thuong
    Research Article

    Antibiotic tolerance in Mycobacterium tuberculosis reduces bacterial killing, worsens treatment outcomes, and contributes to resistance. We studied rifampicin tolerance in isolates with or without isoniazid resistance (IR). Using a minimum duration of killing assay, we measured rifampicin survival in isoniazid-susceptible (IS, n=119) and resistant (IR, n=84) isolates, correlating tolerance with bacterial growth, rifampicin minimum inhibitory concentrations (MICs), and isoniazid-resistant mutations. Longitudinal IR isolates were analyzed for changes in rifampicin tolerance and genetic variant emergence. The median time for rifampicin to reduce the bacterial population by 90% (MDK90) increased from 1.23 days (IS) and 1.31 days (IR) to 2.55 days (IS) and 1.98 days (IR) over 15–60 days of incubation, indicating fast and slow-growing tolerant sub-populations. A 6 log10-fold survival fraction classified tolerance as low, medium, or high, showing that IR is linked to increased tolerance and faster growth (OR = 2.68 for low vs. medium, OR = 4.42 for low vs. high, p-trend = 0.0003). High tolerance in IR isolates was associated with rifampicin treatment in patients and genetic microvariants. These findings suggest that IR tuberculosis should be assessed for high rifampicin tolerance to optimize treatment and prevent the development of multi-drug-resistant tuberculosis.

    1. Evolutionary Biology
    2. Microbiology and Infectious Disease
    Zachary H Williams, Alvaro Dafonte Imedio ... Welkin E Johnson
    Research Article Updated

    HERV-K(HML-2), the youngest clade of human endogenous retroviruses (HERVs), includes many intact or nearly intact proviruses, but no replication competent HML-2 proviruses have been identified in humans. HML-2-related proviruses are present in other primates, including rhesus macaques, but the extent and timing of HML-2 activity in macaques remains unclear. We have identified 145 HML-2-like proviruses in rhesus macaques, including a clade of young, rhesus-specific insertions. Age estimates, intact open reading frames, and insertional polymorphism of these insertions are consistent with recent or ongoing infectious activity in macaques. 106 of the proviruses form a clade characterized by an ~750 bp sequence between env and the 3′ long terminal repeat (LTR), derived from an ancient recombination with a HERV-K(HML-8)-related virus. This clade is found in Old World monkeys (OWM), but not great apes, suggesting it originated after the ape/OWM split. We identified similar proviruses in white-cheeked gibbons; the gibbon insertions cluster within the OWM recombinant clade, suggesting interspecies transmission from OWM to gibbons. The LTRs of the youngest proviruses have deletions in U3, which disrupt the Rec Response Element (RcRE), required for nuclear export of unspliced viral RNA. We show that the HML-8-derived region functions as a Rec-independent constitutive transport element (CTE), indicating the ancestral Rec–RcRE export system was replaced by a CTE mechanism.